Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)
Funding Opportunity PAR-23-284 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) invites applications for P50 Research Center Grants for Specialized Programs of Research Excellence (SPORE). The program will fund P50 SPORE grants to support state-of-the-art investigator-initiated translational research that will contribute to improved prevention, early detection, diagnosis, and treatment of an organ-specific cancer or a highly related group of cancers. For the purpose of this FOA, a group of highly related cancers are those that are deriv...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 22, 2023 Category: Research Source Type: funding
A Consortium for Gut-Brain Communication in Parkinsons Disease (U24 Clinical Trial not allowed)
Funding Opportunity RFA-DK-23-001 from the NIH Guide for Grants and Contracts. Parkinsons disease (PD) is the second most common and fastest growing neurodegenerative disorder, with approximately 60,000 Americans diagnosed annually. PD symptoms are not limited to motor dysfunction and more than 50% of patients who develop PD often have a history of bowel complaints affecting nearly all parts of the gastrointestinal (GI) system. These SI symptoms often precede the onset of motor symptoms, indicating that GI dysfunction may be an early manifestation of the disease and the gut may be an unexplored diagnostic and/or therape...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 31, 2023 Category: Research Source Type: funding
A Consortium for Gut-Brain Communication in Parkinsons Disease (U01 Clinical Trial Not Allowed)
The objective of this consortium is to accelerate research on the role gastrointestinal (GI) symptoms and changes in gut-brain communication in the initiation and pathogenesis of Parkinsons disease in order to facilitate development and validation of innovative early-phase GI-based diagnostic tools and biomarkers for PD. The research centers of the GBPDC will serve as sites for enrollment of PD patients with and without GI symptoms, patients with GI symptoms considered to be at risk for PD, and healthy age-matched controls for laboratory-based studies on biological samples obtained from these patients. The NIDDK strongly e...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 31, 2023 Category: Research Source Type: funding
Notice of Pre-Application Webinar for the "Program on the Origins of Gastroesophageal Cancers": RFA-CA-21-026 and RFA-CA-21-027
Notice NOT-CA-21-107 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 13, 2021 Category: Research Source Type: funding
Notice of Special Interest: Advancing Research in Gastrointestinal Dysfunction in People with Neurodevelopmental Disorders
Notice NOT-DK-21-024 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 6, 2021 Category: Research Source Type: funding
Notice of Special Interest: Advancing Research in Gastrointestinal Dysfunction in People with Neurodevelopmental Disorders
Notice NOT-NS-22-003 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 14, 2021 Category: Research Source Type: funding
Program on the Origins of Gastroesophageal Cancers (R01 Clinical Trial Optional)
Funding Opportunity RFA-CA-21-026 from the NIH Guide for Grants and Contracts. The National Cancer Institute (NCI) is publishing this Funding Opportunity Announcement (FOA) to request applications for the Program on the Origins of Gastroesophageal Cancers (R01). This new program will build on recent molecular classifications of gastroesophageal cancers, significant understanding of their cancer genomics, and advances in stem cell research to examine and define how these related cancers initially evolve at the cellular level. The program will address the complex mechanisms and effectors that direct the proliferation and ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 25, 2021 Category: Research Source Type: funding
Coordinating Center for the Program on the Origins of Gastroesophageal Cancers (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-21-027 from the NIH Guide for Grants and Contracts. The National Cancer Institute (NCI) is publishing this Funding Opportunity Announcement (FOA) to request applications for the Coordinating Center, Program on the Origins of Gastroesophageal Cancers (U24). This new program will build on recent molecular classifications of gastroesophageal cancers, significant understanding of their cancer genomics, and advances in stem cell research to examine and define how these related cancers initially evolve at the cellular level. The program will address the complex mechanisms and effectors that direct t...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 25, 2021 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Program on the Origins of Gastroesophageal Cancers (U24 Clinical Trial Not Allowed)
Notice NOT-CA-21-040 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 19, 2021 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Program on the Origins of Gastroesophageal Cancers (R01 Clinical Trial Optional)
Notice NOT-CA-21-039 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 19, 2021 Category: Research Source Type: funding
Understanding the Cellular and Molecular Mechanisms of Gastroparesis in Adults and Children (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-20-030 from the NIH Guide for Grants and Contracts. Since its establishment in 2006, the Gastroparesis Clinical Research Consortium (GpCRC), a multi-center coalition created and funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), has made major advances to our understanding of the pathophysiology of gastroparesis (Gp) and develop an effective treatment for patients with symptomatic gastroparesis. Through the establishment of the largest gastroparesis tissue repository, combined with detailed phenotypic data, the GpCRC is ideally suited to accelerate insights...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 13, 2020 Category: Research Source Type: funding
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, and 2023 (P50 Clinical Trial Required)
Funding Opportunity PAR-20-305 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) invites applications for P50 Research Center Grants for Specialized Programs of Research Excellence (SPORE). The program will fund P50 SPORE grants to support state-of-the-art investigator-initiated translational research that will contribute to improved prevention, early detection, diagnosis, and treatment of an organ-specific cancer or a highly related group of cancers. For the purpose of this FOA, a group of highly related cancers are those that are deriv...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 28, 2020 Category: Research Source Type: funding
Limited Competition for the Continuation of the Scientific Data Research Center (SDRC) for the NIDDK Gastroparesis Consortium (U24 Clinical Trial Optional)
Funding Opportunity RFA-DK-20-505 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites an application for the Scientific Data Research Center (SDRC) of the Gastroparesis Clinical Research Consortium (GpCRC). The companion FOA, RFA-DK-20-504 will support continuation of the GpCRC Clinical Centers (CC). The Consortium forms a multi-disciplinary teams composed of members from the CCs and SDRC to undertake a comprehensive clinical, epidemiological and biological characterization of adult and children patients with GP to gain insight into the pathophysiology of GP and its sequela: ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 24, 2020 Category: Research Source Type: funding
Limited Competition for the Continuation of Clinical Centers to Investigate the Pathogenesis, Etiology, and Treatment of Gastroparesis through the NIDDK Gastroparesis Consortium (U01 Clinical Trial Optional)
Funding Opportunity RFA-DK-20-504 from the NIH Guide for Grants and Contracts. The primary purpose of this Limited Competition Funding Opportunity Announcement (FOA) is to invite applications from the clinical sites that have participated in the NIDDK Gastroparesis Clinical Research Consortium (GPRCR), to support the ongoing GPCRC cohorts, including the first U.S. registry of children and adolescents with gastroparesis, to support ongoing clinical trials and to provide a platform for informative ancillary studies. In addition, a major collaborative effort within the Consortium will be the establishment of an annotated r...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 24, 2020 Category: Research Source Type: funding
Mucosal Immunology Studies Team (MIST) (U01 Clinical Trial Not Allowed).
Funding Opportunity RFA-AI-20-027 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications from institutions/organizations to participate in a cooperative research group, the Mucosal Immunology Studies Team (MIST), focusing on immune mechanisms and immune regulation at mucosal surfaces of the respiratory, gastrointestinal and urogenital tracts. The main objective of this program is to break new ground in the understanding of basic mucosal immune mechanisms by introducing new ideas, approaches and technologies that address the difficult questions i...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 24, 2020 Category: Research Source Type: funding
